Dr. Jihui Hao, Oncologist, CAR-T Cell Therapy Specialist - Beijing, China

About Dr. Jihui Hao: Leading Oncologist & CAR-T Cell Therapy Specialist in Beijing, China

Dr. Jihui Hao is a highly esteemed and globally recognized oncologist and a prominent expert in advanced cancer treatment in China. Currently practicing at the prestigious Beijing Bioocus International Medical Center, Dr. Hao brings unparalleled expertise, a visionary approach, and decades of clinical excellence to the field of oncology. For patients seeking progressive, innovative oncological care—specifically groundbreaking treatments like Chimeric Antigen Receptor T-cell (CAR-T) therapy—Dr. Jihui Hao offers profound medical knowledge combined with a commitment to significantly advancing patient outcomes on a global scale.

With an illustrious medical career that spans exceptional clinical practice, groundbreaking academic research, and influential leadership within China’s elite medical community, Dr. Hao stands as a pioneer in modern cancer therapeutics. His dedication to pushing the absolute boundaries of medical science and delivering high-quality, patient-centered care has solidified his reputation as a leading figure in precision oncology. His dual role as a high-level academic and a compassionate clinician ensures that patients receive the most advanced and highly effective treatments available today, seamlessly translating complex laboratory research into direct, life-saving patient benefits.

Beyond his primary practice at Beijing Bioocus International Medical Center, Dr. Hao holds prominent directorial and leadership roles at major medical institutions, including serving as the Director of Tianjin Airport Hospital and Tianjin Cancer Hospital. This broad scope of leadership underscores his vast expertise across various cancer treatments and patient care paradigms. Whether dealing with complex blood cancers or intricate solid tumors, patients who choose Dr. Jihui Hao are placing their health in the hands of a distinguished authority in the oncology sector.

Medical Expertise & Specializations

Dr. Jihui Hao’s expertise sits at the absolute forefront of modern oncological science. As a pioneer in CAR-T cell therapy in China, he provides innovative hope and scientifically backed treatment options for patients diagnosed with complex, treatment-resistant cancers. His approach integrates precision medicine—tailoring therapies to the specific genetic makeup of a patient's tumor—with advanced surgical and immunological interventions. His active involvement in national and regional anti-cancer associations highlights his commitment to developing robust, multidimensional cancer treatment strategies.

Conditions Treated

Drawing upon his extensive clinical background and leadership in specialized medical committees, Dr. Hao provides expert diagnostic and therapeutic care for a wide spectrum of complex malignancies, including:

• Leukemia and Hematologic Malignancies: Utilizing advanced cellular therapies to treat severe blood cancers.
• Pancreatic Cancer: Leveraging his expertise as the Vice Chairman of the Pancreatic Cancer Professional Committee to treat one of the most challenging solid tumors.
• Hepatobiliary Cancers: Diagnosing and managing cancers of the liver, gallbladder, and bile ducts through his specialized surgical and oncological knowledge.
• Refractory and Relapsed Cancers: Offering second-line and third-line advanced therapeutic options for cancers that have stopped responding to standard chemotherapy or radiation.

Procedures Performed

Dr. Hao is highly proficient in administering and overseeing complex oncological protocols. His procedural and therapeutic repertoire includes:

• CAR-T Cell Therapy: A revolutionary immunotherapy that involves modifying a patient's own T-cells to specifically recognize, attack, and destroy cancer cells.
• Precision Medicine Oncology: Formulating individualized cancer treatment plans based on comprehensive genomic profiling and molecular diagnostics.
• Hepatobiliary and Pancreatic Surgery Oversight: Guiding surgical oncology interventions for tumors located in the liver, pancreas, and biliary systems.
• Advanced Immunotherapy Protocols: Implementing cutting-edge immune-modulating treatments to boost the body's natural defenses against malignant tumors.

Education, Training & Professional Affiliations

Dr. Jihui Hao’s illustrious background is characterized by rigorous academic achievements and highly influential leadership appointments. As a Chief Physician, Professor, and Doctoral Supervisor, he plays an active role in shaping the next generation of top-tier medical professionals in China. His commitment to scientific advancement is evident through his editorial and board positions, proving his dedication to the continuous research, development, and implementation of the latest advancements in clinical oncology.

• Director: Tianjin Airport Hospital & Tianjin Cancer Hospital
• Standing Director: Chinese Anti-Cancer Association
• Chairman: Tianjin Anti-Cancer Association
• Incoming Chairman: Precision Medicine Professional Committee, Chinese Anti-Cancer Association
• Vice Chairman: Pancreatic Cancer Professional Committee, Chinese Anti-Cancer Association
• Vice Chairman: Hepatobiliary and Pancreatic Surgery Committee, Chinese Medical Education Association
• Executive Editor: Cancer Biology & Medicine, Chinese Journal of Clinical Oncology

What Patients Say About Dr. Jihui Hao

Dr. Hao’s approach to oncology combines high-level academic rigor with profound patient compassion. At the Beijing Bioocus International Medical Center, he and his team have garnered perfect 5-star ratings from international and domestic patients alike, including highly positive feedback from patients such as Wang Jing Yi, Benjamin Reynolds, Zhang Xin Hua, Emma Thompson, and Olivia Davis. Below is a verifiable testimonial from a patient who underwent advanced treatment under this exceptional clinical framework.

Frequently Asked Questions (FAQ)